Johnson Johnson CFO on Q3 earnings, Covid vaccine booster
CNBC s Meg Tirrell and the Squawk Box team sit down with Johnson Johnson CFO Joseph Wolk to discuss the company s latest quarterly earnings, as well as its regulatory bid for a Covid19 vaccine booster. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Johnson Johnson said it sold 502 million of its Covid19 vaccine in the third quarter, in its earnings report Tuesday that beat Wall Streets profit expectations. Heres how J J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:
|
|